---
title: "Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294856082.md"
description: "Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation"
datetime: "2026-08-04T18:03:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294856082.md)
  - [en](https://longbridge.com/en/news/294856082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294856082.md)
generator: "portal-rs"
---

# Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation


### Related Stocks

- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)

## Related News & Research

- [Corcept Chief Business Officer Gary Charles Robb sells 10,000 shares for $1.16 million](https://longbridge.com/en/news/296267228.md)
- [Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of Stock](https://longbridge.com/en/news/296332659.md)
- [Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 million](https://longbridge.com/en/news/296533256.md)
- [Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Director Sells $12,251,409.50 in Stock](https://longbridge.com/en/news/296607178.md)
- [BlackRock Inc. Makes New $1.08 Billion Investment in Corcept Therapeutics Incorporated $CORT](https://longbridge.com/en/news/296675400.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**